Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zielinski, Daniel C ^a   Jamshidi, Neema ^b   Corbett, Austin J ^b   Bordbar, Aarash ^a   Thomas, Alex ^c,d,e   Palsson, Bernhard O ^a,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUTAMINE;

BIOMASS; GLYCOLYSIS; HUMAN; METABOLIC FLUX ANALYSIS; METABOLISM; METABOLOME; NEOPLASM; PATHOLOGY; PHENOTYPE; PROCEDURES; PROTEIN SYNTHESIS; SYSTEMS BIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; BIOMASS; CELL LINE, TUMOR; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HUMANS; METABOLIC FLUX ANALYSIS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; NEOPLASMS; PHENOTYPE; PROTEIN BIOSYNTHESIS; SYSTEMS BIOLOGY;

EID: 85010962151     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41241     Document Type: Article

References (65)

1. Seyfried, T. N., Flores, R. E., Poff, A. M. & DAgostino, D. P. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 35, 515-527, doi: 10.1093/carcin/bgt480 (2014).
2. Warburg, O. On the origin of cancer cells. Science 123, 309-314 (1956).
3. Wise, D. R. & Thompson, C. B. Glutamine addiction: A new therapeutic target in cancer. Trends Biochem Sci 35, 427-433, doi: 10.1016/j.tibs.2010.05.003 (2010).
4. Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R. & Ruppin, E. Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Comput Biol 7, e1002018, doi: 10.1371/journal.pcbi.1002018 (2011).
5. Beardmore, R. E., Gudelj, I., Lipson, D. A. & Hurst, L. D. Metabolic trade-offs and the maintenance of the fittest and the flattest. Nature 472, 342-346, doi: 10.1038/nature09905 (2011).
6. Huang, W. et al. A proposed role for glutamine in cancer cell growth through acid resistance. Cell Res 23, 724-727, doi: 10.1038/cr.2013.15 (2013).
7. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029-1033, doi: 10.1126/science.1160809 (2009).
8. Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27, 441-464, doi: 10.1146/annurev-cellbio-092910-154237 (2011).
9. Vander Heiden, M. G. Targeting cancer metabolism: A therapeutic window opens. Nat Rev Drug Discov 10, 671-684, doi: 10.1038/nrd3504 (2011).
10. Shoemaker, R. H. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6, 813-823, doi: nrc1951 (2006).
11. Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040-1044, doi: 10.1126/science.1218595 (2012).
12. Abaan, O. D. et al. The exomes of the NCI-60 panel: A genomic resource for cancer biology and systems pharmacology. Cancer Res 73, 4372-4382, doi: 10.1158/0008-5472.CAN-12-3342 (2013).
13. Moghaddas Gholami, A. et al. Global proteome analysis of the NCI-60 cell line panel. Cell reports 4, 609-620, doi: 10.1016/j. celrep.2013.07.018 (2013).
14. Dolfi, S. C. et al. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab 1, 20, doi: 10.1186/2049-3002-1-20 (2013).
15. OConnor, P. M. et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57, 4285-4300 (1997).
16. Orth, J. D., Thiele, I. & Palsson, B. O. What is flux balance analysis? Nat Biotechnol 28, 245-248, doi: nbt.1614 (2010).
17. Hyduke, D. R., Lewis, N. E. & Palsson, B. O. Analysis of omics data with genome-scale models of metabolism. Mol Biosyst 9, 167-174, doi: 10.1039/c2mb25453k (2013).
18. Lewis, N. E., Nagarajan, H. & Palsson, B. O. Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol 10, 291-305, doi: 10.1038/nrmicro2737 (2012).
19. Lewis, N. E. & Abdel-Haleem, A. M. The evolution of genome-scale models of cancer metabolism. Front Physiol 4, 237, doi: 10.3389/fphys.2013.00237 (2013).
20. Frezza, C. et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225-228, doi: 10.1038/nature10363 (2011).
21. Asgari, Y., Zabihinpour, Z., Salehzadeh-Yazdi, A., Schreiber, F. & Masoudi-Nejad, A. Alterations in cancer cell metabolism: The Warburg effect and metabolic adaptation. Genomics 105, 275-281, doi: 10.1016/j.ygeno.2015.03.001 (2015).
22. Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat Biotechnol 31, 419-425, doi: 10.1038/nbt.2488 (2013).
23. Roschke, A. V. et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res 63, 8634-8647 (2003).
24. Sheikh, K., Forster, J. & Nielsen, L. K. Modeling hybridoma cell metabolism using a generic genome-scale metabolic model of Mus musculus. Biotechnol Prog 21, 112-121, doi: 10.1021/bp0498138 (2005).
25. Kilburn, D. G., Lilly, M. D. & Webb, F. C. The energetics of mammalian cell growth. J Cell Sci 4, 645-654 (1969).
26. Feist, A. M. & Palsson, B. O. The biomass objective function. Curr Opin Microbiol 13, 344-349, doi: 10.1016/j.mib.2010.03.003 (2010).
27. Metallo, C. M., Walther, J. L. & Stephanopoulos, G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol 144, 167-174, doi: 10.1016/j.jbiotec.2009.07.010 (2009).
28. Forbes, N. S., Meadows, A. L., Clark, D. S. & Blanch, H. W. Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. Metab Eng 8, 639-652, doi: S1096-7176(06)00062-0 (2006).
29. Wagner, B. A., Venkataraman, S. & Buettner, G. R. The rate of oxygen utilization by cells. Free Radic Biol Med 51, 700-712, doi: 10.1016/j.freeradbiomed.2011.05.024 (2011).
30. Zu, X. L. & Guppy, M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313, 459-465, doi: S0006291X0302504X (2004).
31. Kominsky, D. J. et al. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Clin Cancer Res 15, 3442-3450, doi: 10.1158/1078-0432.CCR-08-3291 (2009).
32. De Menezes, Y., De Faria, F. P. & Sesso, A. In human hepatocellular carcinoma cells the total membrane surface area of each major organelle is a particular allometric function of the cytoplasmic volume. A morphometric study. J Submicrosc Cytol Pathol 28, 573-582 (1996).
33. van Hoek, M. J. & Merks, R. M. Redox balance is key to explaining full vs. partial switching to low-yield metabolism. BMC Syst Biol 6, 22, doi: 10.1186/1752-0509-6-22 (2012).
34. Feist, A. M. et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 3, 121, doi: msb4100155 (2007).
35. Vazquez, A., Liu, J., Zhou, Y. & Oltvai, Z. N. Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited. BMC Syst Biol 4, 58, doi: 10.1186/1752-0509-4-58 (2010).
36. DeBerardinis, R. J. et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104, 19345-19350, doi: 0709747104 (2007).
37. Martin, D. S., Bertino, J. R. & Koutcher, J. A. ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res 60, 6776-6783 (2000).
38. Pelicano, H., Martin, D. S., Xu, R. H. & Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene 25, 4633-4646, doi: 1209597 (2006).
39. Zhou, Y. et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res 72, 304-314, doi: 10.1158/0008-5472.CAN-11-1674 (2012).
40. Shen, Y. C. et al. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. Br J Cancer 108, 72-81, doi: 10.1038/bjc.2012.559 (2013).
41. Mateescu, B. et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 17, 1627-1635, doi: 10.1038/nm.2512 (2011).
42. Catanzaro, D. et al. Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death. Oncotarget 6, 30102-30114, doi: 10.18632/oncotarget.4945 (2015).
43. Anastasiou, D. et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283, doi: 10.1126/science.1211485 (2011).
44. Slavov, N., Budnik, B. A., Schwab, D., Airoldi, E. M. & van Oudenaarden, A. Constant growth rate can be supported by decreasing energy flux and increasing aerobic glycolysis. Cell reports 7, 705-714, doi: 10.1016/j.celrep.2014.03.057 (2014).
45. Maciver, N. J. et al. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84, 949-957, doi: 10.1189/jlb.0108024 (2008).
46. Roth, S. & Droge, W. Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. Cell Immunol 108, 417-424 (1987).
47. Kondoh, H. et al. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid Redox Signal 9, 293-299, doi: 10.1089/ars.2006.1467 (2007).
48. Yanes, O. et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 6, 411-417, doi: 10.1038/nchembio.364 (2010).
49. Delgado, T. et al. Induction of the Warburg effect by Kaposis sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci U S A 107, 10696-10701, doi: 10.1073/pnas.1004882107 (2010).
50. Chen, I. T. et al. Six Hours after Infection, the Metabolic Changes Induced by WSSV Neutralize the Hosts Oxidative Stress Defenses. Sci Rep 6, 27732, doi: 10.1038/srep27732 (2016).
51. Phelps, M. E. & Barrio, J. R. Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions? Proc Natl Acad Sci USA 107, 17459-17460, doi: 10.1073/pnas.1012684107 (2010).
52. Higuera, G. A. et al. Patterns of amino acid metabolism by proliferating human mesenchymal stem cells. Tissue Eng Part A 18, 654-664, doi: 10.1089/ten.TEA.2011.0223 (2012).
53. Reaves, M. L., Young, B. D., Hosios, A. M., Xu, Y. F. & Rabinowitz, J. D. Pyrimidine homeostasis is accomplished by directed overflow metabolism. Nature 500, 237-241, doi: 10.1038/nature12445 (2013).
54. Ye, J. et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci USA 109, 6904-6909, doi: 10.1073/pnas.1204176109 (2012).
55. Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350, doi: 10.1038/nature10350 (2011).
56. Hensley, C. T. et al. Metabolic Heterogeneity in Human Lung Tumors. Cell 164, 681-694, doi: 10.1016/j.cell.2015.12.034 (2016).
57. Zong, W. X., Rabinowitz, J. D. & White, E. Mitochondria and Cancer. Mol Cell 61, 667-676, doi: 10.1016/j.molcel.2016.02.011 (2016).
58. Shankavaram, U. T. et al. CellMiner: A relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10, 277, doi: 10.1186/1471-2164-10-277 (2009).
59. Altamirano, C. et al. Analysis of CHO cells metabolic redistribution in a glutamate-based defined medium in continuous culture. Biotechnol Prog 17, 1032-1041, doi: bp0100981 (2001).
60. Bonarius, H. P. et al. Metabolic flux analysis of hybridoma cells in different culture media using mass balances. Biotechnol Bioeng 50, 299-318, doi: 10.1002/(SICI)1097-0290(19960505)50:3 3.0.CO;2-B (1996).
61. Feijo Delgado, F. et al. Intracellular water exchange for measuring the dry mass, water mass and changes in chemical composition of living cells. PLoS One 8, e67590, doi: 10.1371/journal.pone.0067590 (2013).
62. Kit, S., Fiscus, J., Graham, O. L. & Gross, A. L. Metabolism and enzyme content of diploid and tetraploid lympnomas and carcinomas. Cancer Res 19, 201-206 (1959).
63. Frixione, E. & Porter, R. M. Volume and surface changes of smooth endoplasmic reticulum in crayfish retinula cells upon light-And dark-Adaptation. J. Comp. Physiol. 159, 667-674, doi: 10.1007/bf00612039 (1986).
64. Bordbar, A., Monk, J. M., King, Z. A. & Palsson, B. O. Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet 15, 107-120, doi: 10.1038/nrg3643 (2014).
65. Lee, S., Lee, K. H., Song, M. & Lee, D. Building the process-drug-side effect network to discover the relationship between biological processes and side effects. Bmc Bioinformatics 12 Suppl 2, S2, doi: 10.1186/1471-2105-12-S2-S2 (2011).